Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation
F. Marti, N. Pardo, M. Peiro, E. Bertran, B. Amill, J. Garcia, J. Cubells, F. Rueda
Research output: Contribution to journal › Article › peer-review
12Scopus
citations
Fingerprint
Dive into the research topics of 'Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation'. Together they form a unique fingerprint.